Navigation Links
MBF Healthcare Acquisition Corp. and Critical Homecare Solutions Holdings, Inc. to Present at the 2008 UBS Healthcare Services Conference
Date:2/12/2008

te or chronic conditions. CHS delivers over 400,000 infusion pharmaceuticals, biopharmaceuticals, nutrients and related services each year to patients in the home through 33 infusion locations in 14 states, primarily in the eastern United States. CHS also provides over 350,000 nursing and therapy visits and 500,000 private duty nursing hours each year to patients in the home through 32 home nursing locations in three states. CHS currently provides customized local clinical care to over 19,000 patients through its branch network and has relationships with approximately 450 payors, including insurers, managed care organizations and government payors. For more information on CHS please visit the company website at (http://www.criticalhs.com). The information included on the CHS website is not incorporated by reference into this press release or in any filing with the Securities and Exchange Commission.

Additional Information and Where to Find It

MBH expects to file a preliminary proxy statement concerning the previously announced proposed transaction between MBH and CHS, which will be subject to review by the Securities and Exchange Commission. MBH stockholders and other interested persons are urged to read the proxy statement and other relevant materials when they become available as they will contain important information about MBH, CHS and the proposed transaction. Such persons can also read MBH's final prospectus dated April 17, 2007, for a description of the security holdings of the MBH officers and directors and their respective interests in the successful consummation of the proposed transaction. The definitive proxy statement will be mailed to stockholders as of a record date to be established for voting on the proposed transaction.

Participants in Solicitation

MBH and its directors and executive officers and CHS and its directors and executive officers may be deemed to be partici
'/>"/>

SOURCE MBF Healthcare Acquisition Corp.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
5. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
6. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
7. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
8. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
9. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
10. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
11. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... and LONDON, Dec. 15 ... Thomson Pharma ® has become the first drug ... protocol and outcome information. This highly anticipated new ... customers this month. ,, Thomson ... intelligence from registries, publications, press releases, conferences, and ...
(Date:12/15/2009)... The Prinz Law Office has announced the launch of ... businesses secure legal services in the current economic climate. ... them the opportunity to finance legal services over a ... requiring any equity in their start-up companies. The ... for fixed montly payment arrangements over 6 to 12 ...
(Date:12/14/2009)... Dec. 14 Vermillion, Inc. (Pink ... announced William C. Wallen, Ph.D. Chief Scientific ... for IDEXX Laboratories, will be joining its ... bankruptcy plan. ,, "Bill brings more ... in diagnostics and biotechnology," said Gail Page, ...
(Date:12/14/2009)... Rep. Patrick Kennedy Joins with State Biotech ... Leadership in Research and Development while Boosting ... Industry ,, PROVIDENCE, R.I., Dec. 14 ... prominent leaders in research, medicine and biotechnology ... Facility to discuss the importance of medical ...
Breaking Biology Technology:Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4
... LAVAL, QC, Sept. 15 /PRNewswire-FirstCall/ - Neptune ... reported today,that its distributor Schiff Nutrition International ... Oil (NKO(R)) in Walgreens,which represents the largest ... over 6,400 drug stores nationwide. Schiff(R) MegaRed(TM) ...
... - Oncentra(R) RT Viewer* Officially to Launch ... ASTRO 2008, Boston, USA, September,21-24, Nucletron, a ... release of Oncentra RT Viewer. This unique innovation,in ... review,radiotherapy plans that are generated with a wide ...
... Conference, MONTREAL, Sept. 12 /PRNewswire-FirstCall/ - ProMetic ... Pierre Laurin, President,and Chief Executive Officer, will present ... September 16, 2008 at 16:00 (PDT). This event,will ... in San Francisco., More information about the ...
Other Biology Technology:Neptune Krill Oil, NKO(R), enters WALGREENS, the largest U.S. retail pharmacy chain, under the brand name Schiff(R) MegaRed(TM) 2Neptune Krill Oil, NKO(R), enters WALGREENS, the largest U.S. retail pharmacy chain, under the brand name Schiff(R) MegaRed(TM) 3Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy 2ProMetic to present at Merriman Curhan Ford's Investor Summit 2008 on September 16th 2
(Date:12/15/2009)... The mouse is a standard laboratory model organism, ... conventional techniques to analyze blood and blood-forming tissues ... of compact and easy-to-use laboratory resources from Cold ... Mouse Hematology features step-by-step protocols for ... blood, bone marrow, and other hematopoietic tissues in ...
(Date:12/14/2009)... have identified a novel antifreeze molecule in a freeze-tolerant ... degrees Fahrenheit. Unlike all previously described biological antifreezes that ... or no protein. It is composed of a sugar ... places within the cells of organisms. , "The ... molecule is a whole new kind of antifreeze that ...
(Date:12/14/2009)... comprehensive study to date of the proteins in a ... important clues to how similar regeneration could be induced ... Science at Indiana University-Purdue University Indianapolis and colleagues investigated ... axolotls, a type of salamander that has the unique ... amputation, with the hope that this knowledge will contribute ...
Breaking Biology News(10 mins):New source of classical techniques for blood-based studies in the laboratory mouse 2Scientists isolate new antifreeze molecule in Alaska beetle 2IUPUI researchers tackle protein mechanisms behind limb regeneration 2BioConference Live Kicks off Three Day Online Event for Life Science and Biotech Communities Today at 9 3A00 AM Eastern 61505 1BioConference Live Kicks off Three Day Online Event for Life Science and Biotech Communities Today at 9 3A00 AM Eastern 61505 2BioConference Live Kicks off Three Day Online Event for Life Science and Biotech Communities Today at 9 3A00 AM Eastern 61505 3NYC Chiropractor Adds New Therapy for Chronic Back Neck and Joint Pain to Downtown Practice 61503 1NYC Chiropractor Adds New Therapy for Chronic Back Neck and Joint Pain to Downtown Practice 61503 2Obesity Rates Will Continue to Increase Drive Health Care Costs in New Jersey in Next Decade According to New Study 61501 1Obesity Rates Will Continue to Increase Drive Health Care Costs in New Jersey in Next Decade According to New Study 61501 2
... of New South Wales (UNSW) research has highlighted a link ... pregnancy. The work in animals proves that overweight expectant mothers ... who are at greater risk of diabetes and lipid metabolic ... 30 percent of women who become pregnant are overweight. , ...
... Oct. 21 Evolved Machines, Inc. has,been ... new Defense Advanced Research,Projects Agency (DARPA) program ... neural pattern recognition. The $5.1 million,dollar contract ... corporations to,develop a highly versatile and sensitive ...
... non-animal testing deadlines loom for manufacturers of chemicals for ... meeting in Philadelphia will bring together scientists, cosmetics formulators, ... 7th Amendment of the Cosmetics Directive, a series of ... REACH, a massive undertaking to identify potential hazards from ...
Other Biology News:Overweight mums have chubby bubs 2Spotlight on cosmetic ingredients conference 2
Dopamine D2 and D3 receptor, human and possibly mouse. AB1502 detects 40 ng of dopamine receptor peptide by ELISA. AB1502 is not neutralizing....
Rabbit polyclonal to Factor IX ( Abpromise for all tested applications). entrezGeneID: 2158 SwissProtID: P00740...
Adhesion Molecule Antibodies...
Rabbit polyclonal to Glutathione S Transferase alpha ( Abpromise for all tested applications). Antigen: Full length protein: Human Glutathione S Transferase alpha. Entrez GeneID: 2938 Swi...
Biology Products: